ProRx LLC: Drug Recall
Recall #D-0654-2024 · 08/22/2024
Class II: Risk
Recall Details
- Recall Number
- D-0654-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- ProRx LLC
- Status
- Ongoing
- Date Initiated
- 08/22/2024
- Location
- Exton, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 500 vials
Reason for Recall
Lack of Assurance of Sterility
Product Description
Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02
Distribution Pattern
Nationwide in the USA
Other Recalls by ProRx LLC
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
- Class II: Risk 10/15/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.